Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 41 results for "gsk"

Buy GSK Consumer; target of Rs 6102: ICICI Direct

ICICI Direct is bullish on GSK Consumer has recommended buy rating on the stock with a target price of Rs 6102 in its research report dated February 14, 2017. Money Control, 1 week ago

798 images for gsk

WKRB News, 2 weeks ago
WKRB News, 2 weeks ago
Money Control, 1 week ago
Reuters, 1 week ago
Pocket News Alert.com, 3 weeks ago
SleekMoney, 3 weeks ago
Finance Monthly, 3 weeks ago
FiercePharma, 3 weeks ago
FiercePharma, 2 weeks ago
4 Traders, 2 weeks ago

GSK says its eyeing more collaborations for expansion

Patrick Vallance, President - RD, GlaxoSmithKline said the company is looking forward to more collaborations and is looking at a number of options to move ahead with its expansion plans.
 Money Control2 weeks ago GSK eyeing more collaborations for expansion: CEO Vallance  Money Control2 weeks ago

Cipla gets UK nod to sell key inhaler for asthmatics

Firm's Sereflo inhaler is a generic version of GSK's Advair, has a market size of $278 mn in Britain
 Business Standard2 months ago

Blackrock Global sells 2.84 lakh shares of GSK Consumer

On November 30, 2016 Blackrock Global Opportunitiesequity Trust sold 2,84,334 shares of GlaxoSmithKline Consumer Healthcare.
 Money Control2 months ago
Reuters

GSK grabs Astra executive to replace exiting pharma head

GlaxoSmithKline said on Thursday that Abbas Hussain, its global head of pharmaceuticals, is leaving the company and will be replaced by Luke Miels from AstraZeneca. Hussain had been seen as a potential contender to take over from Chief Executive Andrew Witty, ...
 Reuters1 month ago GSK grabs AstraZeneca executive to replace pharma head  DNA1 month ago

Top global pharma firms to participate in BioAsia 2017

Top global pharma firms including Johnson & Johnson, Novartis and GSK have confirmed participation in 14th BioAsia, scheduled to be held here from February 6, officials said.Organized by the Telangana government, the three-day event will bring together ...
 Prokerala1 month ago
Reuters

GSK boosts board-level science as new CEO prepares to take over

Drugmaker GlaxoSmithKline is bolstering scientific expertise on its board by establishing a new science committee, charged with overseeing research, as a new chief executive prepares to take over. Incoming CEO Emma Walmsley, the first woman to lead a top ...
 Reuters2 months ago

BRIEF-GSK reports positive results in study for controlled asthma

GlaxoSmithKline Plc: * Positive results for Relvar Ellipta lung function study in patients with well-controlled asthma * Patients randomised to FF/VI taken once-daily maintained lung function versus those randomised to twice-daily FP/SAL, meeting study's ...
 DNA22 hours ago BRIEF-GSK announces positive final stage results for two-drug HIV treatment  DNA1 week ago

Weak pound buoys GSK but drugmaker warns on 2017 generic threat

GlaxoSmithKline sales and profits jumped in the fourth quarter, helped by falling sterling, but the drugmaker cautioned profit growth could be impacted in 2017 by generic competition to its top-selling lung drug Advair.
 DNA2 weeks ago

GSK Consumer: Volume recovery must for any re-rating

Despite undemanding valuations, missing catalysts could keep a lid on the stock price
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less